How to Cycle Peptides: On/Off Protocols and Desensitization Prevention
Learn how to cycle peptides correctly — standard on/off ratios, which peptides require cycling, receptor desensitization mechanisms, and how to maintain results.
Overview
Peptide cycling — alternating between use periods and rest periods — prevents receptor desensitization, maintains sensitivity, and allows the body to reset. Not all peptides require cycling, but understanding when and how to cycle is essential for long-term effectiveness.
What You Need
- Calendar or tracking app
- Understanding of each peptide's receptor mechanism
Step-by-Step Instructions
Understand which peptides require cycling
GH secretagogues (ipamorelin, CJC-1295, sermorelin): cycle 8–12 weeks on, 4 weeks off to prevent pituitary desensitization. BPC-157/TB-500: can be used continuously for acute healing; cycle after 12 weeks for chronic use. Epithalon: inherently cycled (10–20 day protocols, 1–2x/year). PT-141: limit to 1–2x per month.
Plan your on-cycle
Define the start date, duration (typically 8–12 weeks), and end date before starting. Having a defined end date prevents indefinite use and ensures you take the planned break.
Plan your off-cycle
Off-cycle duration: typically 4 weeks for GH secretagogues, 2–4 weeks for other peptides. During the off-cycle, maintain training and nutrition — most peptide gains are retained with proper lifestyle.
Taper down (optional)
For long cycles (12+ weeks) or high doses, consider tapering the dose over the final 2 weeks rather than stopping abruptly. This reduces the 'crash' feeling some users experience when stopping GH secretagogues.
Track results across cycles
Compare body composition, performance, and subjective wellbeing between cycles. This helps identify diminishing returns and optimize future cycle design.
Common Mistakes to Avoid
Running GH secretagogues indefinitely
Fix: Continuous GH secretagogue use leads to pituitary desensitization and diminishing returns. The 8–12 week on / 4 week off protocol maintains long-term effectiveness.
Stopping abruptly after a long cycle
Fix: Consider a 2-week taper for long cycles. Abrupt cessation of GH secretagogues can cause temporary fatigue and mood changes.
Not tracking results
Fix: Without tracking, it is impossible to know if the cycle is working or if results are being maintained during the off-cycle.
Frequently Asked Questions
Do I need to cycle BPC-157?
BPC-157 does not appear to cause receptor desensitization in the same way as GH secretagogues. For acute injury healing, continuous use for 4–8 weeks is common. For chronic use, cycling every 12 weeks is a reasonable precaution.
What happens if I do not cycle GH secretagogues?
Continuous use of GH secretagogues (ipamorelin, CJC-1295, sermorelin) can lead to pituitary desensitization, reduced GH response, and diminishing results over time. The 8–12 week cycle protocol prevents this.
Can I use different peptides during the off-cycle?
Yes — many users use non-GH peptides (BPC-157, GHK-Cu, epithalon) during the off-cycle from GH secretagogues. This maintains some peptide benefits while allowing the GH axis to reset.
Peptides Covered in This Guide
Related Guides
Not sure which peptide is right for you?
Take our 5-minute quiz to get a personalized peptide recommendation based on your biology and goals.